Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 1
1992 2
1993 1
1995 4
1997 2
1998 1
2000 2
2001 2
2002 6
2003 2
2004 1
2005 1
2006 3
2007 3
2008 2
2009 2
2010 2
2011 3
2012 1
2013 2
2014 4
2015 3
2016 2
2017 1
2018 1
2019 2
2020 1
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Mediastinal T Acute Lymphoblastic Leukemia"
Page 1
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, Ha CS, Keating MJ, Murphy S, Freireich EJ. Kantarjian HM, et al. J Clin Oncol. 2000 Feb;18(3):547-61. doi: 10.1200/JCO.2000.18.3.547. J Clin Oncol. 2000. PMID: 10653870 Clinical Trial.
Median age was 39.5 years; 37% were at least 50 years old. Mature B-cell disease (Burkitt type) was present in 9%, T-cell disease in 17%. Leukocytosis of more than 30 x 10(9)/L was found in 26%, Philadelphia chromosome-positive disease in 16% (20% of patients with a …
Median age was 39.5 years; 37% were at least 50 years old. Mature B-cell disease (Burkitt type) was present in 9%, T-cell dise …
Lymphoblastic lymphoma.
Cortelazzo S, Ferreri A, Hoelzer D, Ponzoni M. Cortelazzo S, et al. Crit Rev Oncol Hematol. 2017 May;113:304-317. doi: 10.1016/j.critrevonc.2017.03.020. Epub 2017 Mar 18. Crit Rev Oncol Hematol. 2017. PMID: 28427520 Review.
Lymphoblastic lymphoma (LBL) is a neoplasm of immature B cells committed to the B-(B-LBL) or T-cell lineage (T-LBL) that accounts for approximately 2% of all lymphomas. Although histological features are usually sufficient to distinguish lymphoblastic …
Lymphoblastic lymphoma (LBL) is a neoplasm of immature B cells committed to the B-(B-LBL) or T-cell lineage (T-LBL) tha …
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, et al. Larson RA, et al. Blood. 1995 Apr 15;85(8):2025-37. Blood. 1995. PMID: 7718875 Free article. Clinical Trial.
The goal of this phase II multicenter clinical trial was to evaluate a new intensive chemotherapy program for adults with untreated acute lymphoblastic leukemia (ALL) and to examine prospectively the impact of clinical and biologic characteristics on t …
The goal of this phase II multicenter clinical trial was to evaluate a new intensive chemotherapy program for adults with untr …
Adult lymphoblastic lymphoma.
Portell CA, Sweetenham JW. Portell CA, et al. Cancer J. 2012 Sep-Oct;18(5):432-8. doi: 10.1097/PPO.0b013e31826b1232. Cancer J. 2012. PMID: 23006948 Review.
Lymphoblastic lymphoma is rare, accounting for 1% to 2% of all non-Hodgkin lymphomas and is of T-cell phenotype in 90% of cases. ...Both express their lineage-specific markers as well as terminal deoxynucleotidyl transferase. The differences are often made on …
Lymphoblastic lymphoma is rare, accounting for 1% to 2% of all non-Hodgkin lymphomas and is of T-cell phenotype in 90% …
Lymphoblastic lymphoma.
Thomas DA, Kantarjian HM. Thomas DA, et al. Hematol Oncol Clin North Am. 2001 Feb;15(1):51-95, vi. doi: 10.1016/s0889-8588(05)70200-8. Hematol Oncol Clin North Am. 2001. PMID: 11253609 Review.
Recent advances in the unique clinicopathologic entity of lymphoblastic lymphoma (and its variants) are discussed in this article, which details the natural history, molecular biology, prognosis, and outcome with various chemotherapy regimens. ...
Recent advances in the unique clinicopathologic entity of lymphoblastic lymphoma (and its variants) are discussed in this article, wh …
Lymphoblastic lymphoma.
Cortelazzo S, Ponzoni M, Ferreri AJ, Hoelzer D. Cortelazzo S, et al. Crit Rev Oncol Hematol. 2011 Sep;79(3):330-43. doi: 10.1016/j.critrevonc.2010.12.003. Epub 2011 Jan 26. Crit Rev Oncol Hematol. 2011. PMID: 21273093 Review.
Lymphoblastic lymphoma (LBL) is a neoplasm of immature B cells committed to the B-(B-LBL) or T-cell lineage (T-LBL) that accounts for approximately 2% of all lymphomas. ...Although histological features are usually sufficient to distinguish lymphoblastic …
Lymphoblastic lymphoma (LBL) is a neoplasm of immature B cells committed to the B-(B-LBL) or T-cell lineage (T-LBL) tha …
Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults.
Patel AA, Thomas J, Rojek AE, Stock W. Patel AA, et al. Curr Treat Options Oncol. 2020 May 28;21(7):57. doi: 10.1007/s11864-020-00757-5. Curr Treat Options Oncol. 2020. PMID: 32468488 Review.
T cell acute lymphoblastic leukemia (T-ALL) occurs in approximately 25-30% of adult ALL diagnoses. ...Measurable residual disease (MRD) has taken on increasing prognostic value in T-ALL and may help to identify which patients should receive an allogeneic stem …
T cell acute lymphoblastic leukemia (T-ALL) occurs in approximately 25-30% of adult ALL diagnoses. ...Measurable residu …
Lymphoblastic lymphoma in adults.
Sweetenham JW. Sweetenham JW. Curr Hematol Malig Rep. 2006 Dec;1(4):241-7. doi: 10.1007/s11899-006-0005-8. Curr Hematol Malig Rep. 2006. PMID: 20425319 Review.
Understanding of the pathogenesis and biology of precursor T-cell and B-cell neoplasms has advanced significantly with the description of gene expression profiling studies, especially in T-cell disease. These studies have demonstrated leukemic a …
Understanding of the pathogenesis and biology of precursor T-cell and B-cell neoplasms has advanced significantly with …
Outcomes of children and young adults with T-cell acute lymphoblastic leukemia/lymphoma who present in critical status.
Wayne NJ, Li Y, Chung P, Coffan K, Rheingold SR. Wayne NJ, et al. Pediatr Blood Cancer. 2022 Apr;69(4):e29457. doi: 10.1002/pbc.29457. Epub 2022 Jan 8. Pediatr Blood Cancer. 2022. PMID: 34997812
BACKGROUND: Patients with T-cell acute lymphoblastic leukemia and lymphoma (T-ALL/LLy) commonly present with critical features such as hyperleukocytosis and mediastinal mass, which complicates completing a diagnostic and staging workup and prevents …
BACKGROUND: Patients with T-cell acute lymphoblastic leukemia and lymphoma (T-ALL/LLy) commonly present with critical f …
Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower-middle-income country.
Sutaryo S, Widjajanto PH, Mulatsih S, Ardianto B, Pangarso AWS, Supriyadi E, Purwanto I, Adelin CP, Lestari RP, Sagoro L, Christian SD, Sabrina DS, Verena N, Kors WA, Kaspers GJL, Veerman AJP. Sutaryo S, et al. Pediatr Blood Cancer. 2022 Nov;69(11):e29875. doi: 10.1002/pbc.29875. Epub 2022 Jul 20. Pediatr Blood Cancer. 2022. PMID: 35856702
BACKGROUND: The prognosis of childhood acute lymphoblastic leukemia (ALL) in Indonesia, a lower-middle-income country (LMIC), is lower than in high income countries (HICs). ...HR was defined as age over 10 years, leucocyte count over 50 10(9) /L, central nervous system (CN …
BACKGROUND: The prognosis of childhood acute lymphoblastic leukemia (ALL) in Indonesia, a lower-middle-income country (LMIC), is lowe …
61 results